Annual report
4021.TEDINET S100W4RP
Period2023-04-01 → 2024-03-31
Filed2025-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100TUZY. Amended by S100W5L5 (2025-06-25).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥226.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥228.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥208.0bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥209.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥206.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥48.2bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥52.3bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥51.6bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥55.8bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥53.7bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥43.9bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥40.0bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥51.8bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥56.6bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥38.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥41.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥38.8bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥33.5bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥30.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥38.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥41.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥323.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥298.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥279.7bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥265.5bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥249.5bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥92.6bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥77.2bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥230.9bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥221.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥208.0bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥200.6bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥185.5bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥22.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥29.6bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥22.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥30.6bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥33.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥41.9bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥39.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥35.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥18.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥19.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥12.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥12.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥15.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥22.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥25.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥27.9bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥25.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥25.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥272.82 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥291.36 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥271.88 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥231.73 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥210.09 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,641.05 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,557.12 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,454.01 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,384.13 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,264.23 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 70.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.6% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.9% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 17.1% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.4% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.2% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.5% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.9% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,137 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 2,965 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 2,737 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 2,688 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 2,640 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥181.2bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥183.2bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥170.0bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥162.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥160.2bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥40.9bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥41.8bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥45.0bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥46.4bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥46.5bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥39.3bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥37.5bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥44.9bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥47.2bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥34.6bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥36.2bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥34.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥30.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥29.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥257.6bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥241.8bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥231.0bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥225.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥213.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥80.5bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥67.1bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥177.0bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥174.7bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥168.4bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥165.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥155.4bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥14.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥21.7bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥248 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥256.49 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.21 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥212.52 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥201.76 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥164 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥164 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥122 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥104 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,277.1 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,245.72 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,188.84 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,152.93 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,068.43 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 68.7% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.3% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.9% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.4% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.9% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 19.7% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.1% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 20.6% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.1% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.2% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 138,800,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 141,300,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 143,000,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 145,000,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 146,000,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2,011 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 1,959 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 1,929 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 1,924 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 1,890 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 122
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2023-04-01 → 2024-03-31 | ¥1.8bn |
| Otherother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥748m |
| Otherother segments | employees | at 2024-03-31 | 482 pure |
| Otherother segments | revenue | 2023-04-01 → 2024-03-31 | ¥30.2bn |
| Otherother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥11.2bn |
| Otherother segments | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥19.0bn |
| Otherother segments | segment assets | at 2024-03-31 | ¥21.1bn |
| Otherother segments | segment profit | 2023-04-01 → 2024-03-31 | ¥572m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥468m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥471m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥115.8bn |
| Reconciling Itemsreconciling | revenue external | 2023-04-01 → 2024-03-31 | −¥27.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥88.7bn |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥30.4bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥4.9bn |
| Agrochemicalsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥6.8bn |
| Agrochemicalsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥3.3bn |
| Agrochemicalsreportable segment | employees | at 2024-03-31 | 710 pure |
| Agrochemicalsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥82.1bn |
| Agrochemicalsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥67.4bn |
| Agrochemicalsreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥14.7bn |
| Agrochemicalsreportable segment | segment assets | at 2024-03-31 | ¥119.5bn |
| Agrochemicalsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥23.4bn |
| Chemicalsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥4.2bn |
| Chemicalsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥2.7bn |
| Chemicalsreportable segment | employees | at 2024-03-31 | 380 pure |
| Chemicalsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥35.6bn |
| Chemicalsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥23.5bn |
| Chemicalsreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥12.1bn |
| Chemicalsreportable segment | segment assets | at 2024-03-31 | ¥33.2bn |
| Chemicalsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥48m |
| Medicinesreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥473m |
| Medicinesreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥367m |
| Medicinesreportable segment | employees | at 2024-03-31 | 105 pure |
| Medicinesreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥6.3bn |
| Medicinesreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥6.2bn |
| Medicinesreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥71m |
| Medicinesreportable segment | segment assets | at 2024-03-31 | ¥8.6bn |
| Medicinesreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥2.8bn |
| Performance Materialsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥9.4bn |
| Performance Materialsreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥6.0bn |
| Performance Materialsreportable segment | employees | at 2024-03-31 | 888 pure |
| Performance Materialsreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥84.6bn |
| Performance Materialsreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥67.2bn |
| Performance Materialsreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥17.4bn |
| Performance Materialsreportable segment | segment assets | at 2024-03-31 | ¥70.6bn |
| Performance Materialsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥22.5bn |
| Tradingreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥39m |
| Tradingreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥77m |
| Tradingreportable segment | employees | at 2024-03-31 | 203 pure |
| Tradingreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥103.8bn |
| Tradingreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥78.3bn |
| Tradingreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥25.5bn |
| Tradingreportable segment | segment assets | at 2024-03-31 | ¥40.0bn |
| Tradingreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥3.7bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥22.7bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥13.2bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥342.5bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥253.8bn |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥88.7bn |
| —segment total | segment assets | at 2024-03-31 | ¥293.0bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥53.1bn |
| Otherother segments | capex | 2022-04-01 → 2023-03-31 | ¥366m |
| Otherother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥442m |
| Otherother segments | revenue | 2022-04-01 → 2023-03-31 | ¥26.4bn |
| Otherother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥12.1bn |
| Otherother segments | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥14.3bn |
| Otherother segments | segment assets | at 2023-03-31 | ¥13.6bn |
| Otherother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥879m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥787m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥249m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥107.3bn |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2023-03-31 | −¥29.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥78.1bn |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥41.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥5.2bn |
| Agrochemicalsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥6.2bn |
| Agrochemicalsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥2.7bn |
| Agrochemicalsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥81.6bn |
| Agrochemicalsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥70.3bn |
| Agrochemicalsreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥11.3bn |
| Agrochemicalsreportable segment | segment assets | at 2023-03-31 | ¥104.0bn |
| Agrochemicalsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥23.1bn |
| Chemicalsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥3.7bn |
| Chemicalsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥2.5bn |
| Chemicalsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥39.0bn |
| Chemicalsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥26.5bn |
| Chemicalsreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥12.5bn |
| Chemicalsreportable segment | segment assets | at 2023-03-31 | ¥34.2bn |
| Chemicalsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.4bn |
| Medicinesreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥449m |
| Medicinesreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥376m |
| Medicinesreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥6.7bn |
| Medicinesreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥6.7bn |
| Medicinesreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥11m |
| Medicinesreportable segment | segment assets | at 2023-03-31 | ¥7.7bn |
| Medicinesreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥3.0bn |
| Performance Materialsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥8.7bn |
| Performance Materialsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥4.6bn |
| Performance Materialsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥82.6bn |
| Performance Materialsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥66.2bn |
| Performance Materialsreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥16.4bn |
| Performance Materialsreportable segment | segment assets | at 2023-03-31 | ¥61.3bn |
| Performance Materialsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥25.4bn |
| Tradingreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥66m |
| Tradingreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥65m |
| Tradingreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥99.1bn |
| Tradingreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥75.5bn |
| Tradingreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥23.5bn |
| Tradingreportable segment | segment assets | at 2023-03-31 | ¥36.8bn |
| Tradingreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥3.7bn |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥19.5bn |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥10.6bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥335.4bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥257.2bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥78.1bn |
| —segment total | segment assets | at 2023-03-31 | ¥257.6bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥57.5bn |
| Agrochemicalsreportable segment | employees | at 2024-03-31 | 550 pure |
| Chemicalsreportable segment | employees | at 2024-03-31 | 380 pure |
| Medicinesreportable segment | employees | at 2024-03-31 | 105 pure |
| Performance Materialsreportable segment | employees | at 2024-03-31 | 607 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,860
| Item | Context | Value | Unit |
|---|---|---|---|
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)㈱大阪ソーダ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)主に化学品セグメントにおける営業取引関係の維持・発展を保有目的としております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)日本化薬㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)主に化学品・機能性材料・農業化学品セグメントにおける営業取引関係の維持・発展を保有目的としております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)東京応化工業㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)日本曹達㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)主に化学品・機能性材料・農業化学品におけるセグメント営業取引関係の維持・発展を保有目的としております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)クミアイ化学工業㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)主に農業化学品セグメントにおける営業取引関係の維持・発展を保有目的としております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Original text (Japanese)四国化成ホールディングス㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Original text (Japanese)主に化学品セグメントにおける営業取引関係の維持・発展を保有目的としております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)日清オイリオグループ㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)主に化学品セグメントにおける営業取引関係の維持・発展を保有目的としておりますが、当事業年度に一部売却いたしました。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)三菱瓦斯化学㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)主に化学品・機能性材料セグメントにおける営業取引関係の維持・発展を保有目的としております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | Original text (Japanese)SOMPOホールディングス㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | Original text (Japanese)金融取引関係の維持・発展を保有目的としており、当事業年度は株式分割により保有株式数が増加いたしました。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | Original text (Japanese)保土谷化学工業㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | Original text (Japanese)主に化学品・農業化学品セグメントにおける営業取引関係の維持・発展を保有目的としております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row14Member | Original text (Japanese)㈱クレハ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row14Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row14Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row15Member | Original text (Japanese)北興化学工業㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row15Member | Original text (Japanese)主に農業化学品セグメントにおける営業取引関係の維持・発展を保有目的としております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row15Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row16Member | Original text (Japanese)科研製薬㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row16Member | Original text (Japanese)主に農業化学品セグメントにおける営業取引関係の維持・発展を保有目的としております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row16Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row17Member | Original text (Japanese)カネコ種苗㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row17Member | Original text (Japanese)主に農業化学品セグメントにおける営業取引関係の維持・発展を保有目的としております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row17Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row18Member | Original text (Japanese)稲畑産業㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row18Member | Original text (Japanese)主に機能性材料セグメントにおける営業取引関係の維持・発展を保有目的としておりますが、当事業年度に一部売却いたしました。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row18Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row19Member | Original text (Japanese)東邦化学工業㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row19Member | Original text (Japanese)主に化学品・機能性材料セグメントにおける営業取引関係の維持・発展を保有目的としております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row19Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row20Member | Original text (Japanese)三井住友トラストHD㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row20Member | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |